Introduction: Mutism after posterior fossa tumour resection is generally said to be transient. Our experience suggested that speech did not usually normalise, and that mutism was associated with neurologic deficits that did not recover fully. Methods: Children with mutism after posterior fossa tumour resection, and alive more than 2 years post-operatively, were reviewed retrospectively. Charts were reviewed and parents contacted to ascertain details about mutism, associated neurologic deficits, and the most recent speech and neurologic status. Results: There were 7 children, with follow-up ranging from 2.5 to 13.1 years (mean 6.8 years). Tumours were midline, with 4 astrocytomas and 3 medulloblastomas. Mutism was noted immediately after post-operative extubation in all patients. Speech reappeared 1–15 weeks post-operatively, except for 1 patient, who remained mute at 2.5 years. Speech returned to normal in only 1 patient. Mutism was always accompanied by new or worsened cerebellar ataxia, which resolved incompletely in the long term. Sixth nerve palsies occurred in 3 and recovered incompletely. Seventh nerve paresis occurred in 2 and recovered completely. Conclusion: Mutism after posterior fossa tumour resection is associated with other neurologic deficits, particularly ataxia. Whereas speech usually returns, contrary to general opinion, speech rarely normalises. Other associated deficits rarely resolve completely. These findings have significant implications for counselling of family and patients.

1.
Turgut M: Transient ‘cerebellar’ mutism. Childs Nerv Syst 1998;14:161–166.
2.
Dailey AT, McKhann GM, Berger MS: The pathophysiology of oral pharyngeal apraxia and mutism following posterior fossa tumor resection in children. J Neurosurg 1995;83:467–475.
3.
Doxey D, Bruce D, Sklar F, Swift D, Shapiro K: Posterior fossa syndrome: Identifiable risk factors and irreversible complications. Pediatr Neurosurg 1999;31:131–136.
4.
Ersahin Y, Mutluer S, Cagli S, Duman Y: Cerebellar mutism: Report of seven cases and review of the literature. Neurosurgery 1996;38:60–65.
5.
Gelabert-Gonzalez M, Fernandez-Villa J: Mutism after posterior fossa surgery: Review of the literature. Clin Neurol Neurosurg 2001;103:111–114.
6.
van Dongen HR, Catsman-Berrevoets CE, van Mourik M: The syndrome of ‘cerebellar’ mutism and subsequent dysarthria. Neurology 1994;44:2040–2046.
7.
Pollack IF: Posterior fossa syndrome. Int Rev Neurobiol 1997;41:411–432.
8.
Cochrane DD, Gustavsson B, Poskitt KP, Steinbok P, Kestle JR: The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood. Pediatr Neurosurg 1994;20:19–29.
9.
Hirsch J, Renier D, Czernichow P, Benveniste L, Pierre-Kahn A: Medulloblastoma in childhood: Survival and functional results. Acta Neurochir 1979;48:1–15.
10.
Sakai H, Sekino H, Nakamura N: Three cases of ‘cerebellar mutism’. Shinkeinaika 1980;12:302–304.
11.
Pierre-Kahn A, Mitjaville I, Debray-Ritzen P, Hirsch J: Mutisme après chirurgie de la fosse postérieure chez l’enfant. Rev Neurol (Paris) 1980;136:92.
12.
Wisoff JH, Epstein FJ: Pseudobulbar palsy after posterior fossa operation in children. Neurosurgery 1984;15:707–709.
13.
Rekate H, Grubb R, Aram D, Hahn J, Ratcheson R: Muteness of cerebellar origin. Arch Neurol 1985;42:697–698.
14.
Yonemasu Y: ‘Cerebellar mutism’ and speech disturbance as a complication of posterior fossa surgery in children.13th Annu Meet Jpn Soc for Pediatr Neurosurg, Tsukuba, 1985.
15.
Huber-Okrainec J, Dennis M, Bradley K, Spiegler B: Cerebellar tumor resection in childhood followed by transient cerebellar mutism: An investigation of residual speech deficits in long-term survivors. Annu Meet Pediatr Section of the Am Assoc Neurol Surgeons, New York, 2001.
16.
Asamoto M, Ito H, Suzuki N, Oiwa Y, Saito K, Haraoka J: Transient mutism after posterior fossa surgery. Childs Nerv Syst 1994;10:275–278.
17.
Pollack IF, Polinko P, Albright AL, Towbin R, Fitz C: Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: Incidence and pathophysiology. Neurosurgery 1995;37:885–893.
18.
Siffert J, Poussaint TY, Goumnerova LC, Scott RM, LaValley B, Tarbell NJ, Pomeroy SL: Neurological dysfunction associated with postoperative cerebellar mutism. J Neurooncol 2000;48:75–81.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.